Brookfield Asset Management has emerged as one of several private equity firms pursuing Fakih IVF, a Gulf fertility clinic operator that could command a valuation near $1 billion. The potential acquisition comes as healthcare assets prove resilient amid regional geopolitical uncertainty following Iran's recent military actions.

Fakih IVF operates a network of fertility treatment centers across the Middle East, positioning it as a defensive play in a region where healthcare demand remains steady despite conflict. Private equity interest reflects broader confidence in medical services as recession-resistant investments, particularly in affluent Gulf markets where fertility treatments command premium pricing.

The deal would mark one of the largest healthcare transactions in the region this year, signaling continued appetite for Middle Eastern medical assets despite ongoing tensions. Brookfield's involvement suggests institutional investors view Gulf healthcare infrastructure as a stable long-term bet, even as regional conflicts create short-term volatility.

Middle East fertility clinics have attracted increasing investor attention as birth rates remain high and insurance coverage expands. A successful deal at the rumored valuation would establish a new benchmark for Gulf healthcare assets, potentially spurring additional private equity activity across the sector.